The Applicability of Haarlem Integrated Diagnostic System in Diffuse Glial Tumors and The Role of PDGFRA Amplification as a Marker of Recurrence and Prognosis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.